MAPT and Cognitive impairment: Aβ‐PET (A + T− subjects) was an independent reliable predictor of longitudinal cognitive decline rather than tau pathology (A − T+ subjects), indicating tau accumulation was not closely correlated with future cognitive impairment without being driven by Aβ deposition.